Identification of p53-dependent genes potentially involved in UVB-mediated premature senescence of human skin fibroblasts using siRNA technology

Mechanisms of Ageing and Development

Volumn 129, Issue 3, 2008, Pages 109-119

  Borlon, Céline ^a   Vankoningsloo, Sébastien ^a   Godard, Patrice ^a   Debacq Chainiaux, Florence ^a   Toussaint, Olivier ^a  

^a Department of Biology   (Belgium)

Author keywords

DNA array; Fibroblasts; Gene expression; p53; Senescence; UVB

Indexed keywords

BETA GALACTOSIDASE; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 2A; GELATINASE A; MESSENGER RNA; PROTEIN P53; SMALL INTERFERING RNA; SOMATOMEDIN BINDING PROTEIN 3; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL AGING; CELL PROLIFERATION; DNA BINDING; DNA MICROARRAY; DNA SYNTHESIS; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN FIBROBLAST; ULTRAVIOLET B RADIATION;

BETA-GALACTOSIDASE; CELL AGING; CELL LINE; DNA; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SKIN; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 38949144420     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2007.10.014     Document Type: Article

References (71)

1. Al-Mohanna M.A., Al-Khalaf H.H., Al-Yousef N., and Aboussekhra A. The p16INK4a tumor suppressor controls p21WAF1 induction in response to ultraviolet light. Nucleic Acids Res. 35 (2007) 223-233
2. Alcorta D.A., Xiong Y., Phelps D., Hannon G., Beach D., and Barrett J.C. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 13742-13747
3. Bayreuther K., Rodemann H.P., Hommel R., Dittmann K., Albiez M., and Francz P.I. Human skin fibroblasts in vitro differentiate along a terminal cell lineage. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 5112-5116
4. Beausejour C.M., Krtolica A., Galimi F., Narita M., Lowe S.W., Yaswen P., and Campisi J. Reversal of human cellular senescence: roles of the p53 and p16 pathways. Embo J. 22 (2003) 4212-4222
5. Berry M.D., and Boulton A.A. Glyceraldehyde-3-phosphate dehydrogenase and apoptosis. J. Neurosci. Res. 60 (2000) 150-154
6. Borlon C., Debacq-Chainiaux F., Hinrichs C., Scharffetter-Kochanek K., Toussaint O., and Wlaschek M. The gene expression profile of psoralen plus UVA-induced premature senescence in skin fibroblasts resembles a combined DNA-damage and stress-induced cellular senescence response phenotype. Exp. Gerontol. 42 (2007) 911-923
7. Brack C., Lithgow G., Osiewacz H., and Toussaint O. EMBO Workshop Report: Molecular and Cellular Gerontology Serpiano. Switzerland, September 18-22, 1999. Embo J. 19 (2000) 1929-1934
8. Brash D.E., Ziegler A., Jonason A.S., Simon J.A., Kunala S., and Leffell D.J. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J. Invest. Dermatol. Symp. Proc. 1 (1996) 136-142
9. Buckbinder L., Talbott R., Velasco-Miguel S., Takenaka I., Faha B., Seizinger B.R., and Kley N. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377 (1995) 646-649
10. Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 11 (2001) S27-S31
11. Chen Q., and Ames B.N. Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 4130-4134
12. Chen R.W., Saunders P.A., Wei H., Li Z., Seth P., and Chuang D.M. Involvement of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and p53 in neuronal apoptosis: evidence that GAPDH is upregulated by p53. J. Neurosci. 19 (1999) 9654-9662
13. de Longueville F., Surry D., Meneses-Lorente G., Bertholet V., Talbot V., Evrard S., Chandelier N., Pike A., Worboys P., Rasson J.P., Le Bourdelles B., and Remacle J. Gene expression profiling of drug metabolism and toxicology markers using a low-density DNA microarray. Biochem. Pharmacol. 64 (2002) 137-149
14. de Magalhaes J.P., Chainiaux F., de Longueville F., Mainfroid V., Migeot V., Marcq L., Remacle J., Salmon M., and Toussaint O. Gene expression and regulation in H2O2-induced premature senescence of human foreskin fibroblasts expressing or not telomerase. Exp. Gerontol. 39 (2004) 1379-1389
15. de Veer M.J., Sledz C.A., and Williams B.R. Detection of foreign RNA: implications for RNAi. Immunol. Cell Biol. 83 (2005) 224-228
16. Debacq-Chainiaux F., Borlon C., Pascal T., Royer V., Eliaers F., Ninane N., Carrard G., Friguet B., de Longueville F., Boffe S., Remacle J., and Toussaint O. Repeated exposure of human skin fibroblasts to UVB at subcytotoxic level triggers premature senescence through the TGF-beta1 signaling pathway. J. Cell Sci. 118 (2005) 743-758
17. Di Fulvio M., Henkels K.M., and Gomez-Cambronero J. Short-hairpin RNA-mediated stable silencing of Grb2 impairs cell growth and DNA synthesis. Biochem. Biophys. Res. Commun. 357 (2007) 737-742
18. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 9363-9367
19. Dumont P., Burton M., Chen Q.M., Gonos E.S., Frippiat C., Mazarati J.B., Eliaers F., Remacle J., and Toussaint O. Induction of replicative senescence biomarkers by sublethal oxidative stresses in normal human fibroblast. Free Radic. Biol. Med. 28 (2000) 361-373
20. Faussillon M., Monnier L., Junien C., and Jeanpierre C. Frequent overexpression of cyclin D2/cyclin-dependent kinase 4 in Wilms' tumor. Cancer Lett. 221 (2005) 67-75
21. Gao C., Zou Z., Xu L., Moul J., Seth P., and Srivastava S. p53-Dependent induction of heat shock protein 27 (HSP27) expression. Int. J. Cancer 88 (2000) 191-194
22. Gartel A.L., Serfas M.S., and Tyner A.L. p21-Negative regulator of the cell cycle. Proc. Soc. Exp. Biol. Med. 213 (1996) 138-149
23. Gillet J.P., Efferth T., Steinbach D., Hamels J., de Longueville F., Bertholet V., and Remacle J. Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes. Cancer Res. 64 (2004) 8987-8993
24. Green L.M., Reade J.L., and Ware C.F. Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines. J. Immunol. Methods 70 (1984) 257-268
25. Grimberg A., Coleman C.M., Shi Z., Burns T.F., MacLachlan T.K., Wang W., and El-Deiry W.S. Insulin-like growth factor binding protein-2 is a novel mediator of p53 inhibition of insulin-like growth factor signaling. Cancer Biol. Ther. 5 (2006) 1408-1414
26. Hall P.A., McKee P.H., Menage H.D., Dover R., and Lane D.P. High levels of p53 protein in UV-irradiated normal human skin. Oncogene 8 (1993) 203-207
27. Hara E., Smith R., Parry D., Tahara H., Stone S., and Peters G. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol. 16 (1996) 859-867
28. Hartwell L.H., and Kastan M.B. Cell cycle control and cancer. Science 266 (1994) 1821-1828
29. Helenius M., Makelainen L., and Salminen A. Attenuation of NF-kappaB signaling response to UVB light during cellular senescence. Exp. Cell Res. 248 (1999) 194-202
30. Hollstein M., Rice K., Greenblatt M.S., Soussi T., Fuchs R., Sorlie T., Hovig E., Smith-Sorensen B., Montesano R., and Harris C.C. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 22 (1994) 3551-3555
31. Jackson A.L., Burchard J., Schelter J., Chau B.N., Cleary M., Lim L., and Linsley P.S. Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity. RNA 12 (2006) 1179-1187
32. Kastan M.B., Onyekwere O., Sidransky D., Vogelstein B., and Craig R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51 (1991) 6304-6311
33. Keyse S.M. The induction of gene expression in mammalian cells by radiation. Semin. Cancer Biol. 4 (1993) 119-128
34. Kim K.H., Park G.T., Lim Y.B., Rue S.W., Jung J.C., Sonn J.K., Bae Y.S., Park J.W., and Lee Y.S. Expression of connective tissue growth factor, a biomarker in senescence of human diploid fibroblasts, is up-regulated by a transforming growth factor-beta-mediated signaling pathway. Biochem. Biophys. Res. Commun. 318 (2004) 819-825
35. Ko L.J., and Prives C. p53: puzzle and paradigm. Genes Dev. 10 (1996) 1054-1072
36. Konopleva M., Zhao S., Xie Z., Segall H., Younes A., Claxton D.F., Estrov Z., Kornblau S.M., and Andreeff M. Apoptosis. Molecules and mechanisms. Adv. Exp. Med. Biol. 457 (1999) 217-236
37. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
38. Levine A.J., Hu W., and Feng Z. The P53 pathway: what questions remain to be explored?. Cell Death Differ. 13 (2006) 1027-1036
39. Li G., and Ho V.C. p53-dependent DNA repair and apoptosis respond differently to high- and low-dose ultraviolet radiation. Br. J. Dermatol. 139 (1998) 3-10
40. Lu X., and Lane D.P. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes?. Cell 75 (1993) 765-778
41. Maki C.G., Huibregtse J.M., and Howley P.M. In vivo ubiquitination and proteasome-mediated degradation of p53(1). Cancer Res. 56 (1996) 2649-2654
42. May P., and May E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18 (1999) 7621-7636
43. Mendes O., Kim H.T., Lungu G., and Stoica G. MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2. Clin. Exp. Metastasis (2007)
44. Mercer W.E. Cell cycle regulation and the p53 tumor suppressor protein. Crit. Rev. Eukaryot. Gene Expr 2 (1992) 251-263
45. Migliaccio E., Giorgio M., Mele S., Pelicci G., Reboldi P., Pandolfi P.P., Lanfrancone L., and Pelicci P.G. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402 (1999) 309-313
46. Miyashita T., and Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80 (1995) 293-299
47. Nair R.R., Solway J., and Boyd D.D. Expression cloning identifies transgelin (SM22) as a novel repressor of 92-kDa type IV collagenase (MMP-9) expression. J. Biol. Chem. 281 (2006) 26424-26436
48. Pascal T., Debacq-Chainiaux F., Chretien A., Bastin C., Dabee A.F., Bertholet V., Remacle J., and Toussaint O. Comparison of replicative senescence and stress-induced premature senescence combining differential display and low-density DNA arrays. FEBS Lett. 579 (2005) 3651-3659
49. Patterson T.A., Lobenhofer E.K., Fulmer-Smentek S.B., Collins P.J., Chu T.M., Bao W., Fang H., Kawasaki E.S., Hager J., Tikhonova I.R., Walker S.J., Zhang L., Hurban P., de Longueville F., Fuscoe J.C., Tong W., Shi L., and Wolfinger R.D. Performance comparison of one-color and two-color platforms within the MicroArray Quality Control (MAQC) project. Nat. Biotechnol. 24 (2006) 1140-1150
50. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001) e45
51. Renard P., Ernest I., Houbion A., Art M., Le Calvez H., Raes M., and Remacle J. Development of a sensitive multi-well colorimetric assay for active NFkappaB. Nucleic Acids Res. 29 (2001) E21
52. Saeed A.I., Sharov V., White J., Li J., Liang W., Bhagabati N., Braisted J., Klapa M., Currier T., Thiagarajan M., Sturn A., Snuffin M., Rezantsev A., Popov D., Ryltsov A., Kostukovich E., Borisovsky I., Liu Z., Vinsavich A., Trush V., and Quackenbush J. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34 (2003) 374-378
53. Salih D.A., Tripathi G., Holding C., Szestak T.A., Gonzalez M.I., Carter E.J., Cobb L.J., Eisemann J.E., and Pell J.M. Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 4314-4319
54. Scharffetter-Kochanek K., Brenneisen P., Wenk J., Herrmann G., Ma W., Kuhr L., Meewes C., and Wlaschek M. Photoaging of the skin from phenotype to mechanisms. Exp. Gerontol. 35 (2000) 307-316
55. Scharffetter-Kochanek K., Wlaschek M., Brenneisen P., Schauen M., Blaudschun R., and Wenk J. UV-induced reactive oxygen species in photocarcinogenesis and photoaging. Biol. Chem. 378 (1997) 1247-1257
56. Semczuk A., and Jakowicki J.A. Alterations of pRb1-cyclin D1-cdk4/6-p16(INK4A) pathway in endometrial carcinogenesis. Cancer Lett. 203 (2004) 1-12
57. Semczuk A., Miturski R., Skomra D., and Jakowicki J.A. Expression of the cell-cycle regulatory proteins (pRb, cyclin D1, p16INK4A and cdk4) in human endometrial cancer: correlation with clinicopathological features. Arch. Gynecol. Obstet. 269 (2004) 104-110
58. Shannan B., Seifert M., Boothman D.A., Tilgen W., and Reichrath J. Clusterin and DNA repair: a new function in cancer for a key player in apoptosis and cell cycle control. J. Mol. Histol. 37 (2006) 183-188
59. Shi L., Reid L.H., Jones W.D., Shippy R., Warrington J.A., Baker S.C., Collins P.J., de Longueville F., Kawasaki E.S., Lee K.Y., Luo Y., Sun Y.A., Willey J.C., Setterquist R.A., Fischer G.M., Tong W., Dragan Y.P., Dix D.J., Frueh F.W., Goodsaid F.M., Herman D., Jensen R.V., Johnson C.D., Lobenhofer E.K., Puri R.K., Schrf U., Thierry-Mieg J., Wang C., Wilson M., Wolber P.K., Zhang L., Amur S., Bao W., Barbacioru C.C., Lucas A.B., Bertholet V., Boysen C., Bromley B., Brown D., Brunner A., Canales R., Cao X.M., Cebula T.A., Chen J.J., Cheng J., Chu T.M., Chudin E., Corson J., Corton J.C., Croner L.J., Davies C., Davison T.S., Delenstarr G., Deng X., Dorris D., Eklund A.C., Fan X.H., Fang H., Fulmer-Smentek S., Fuscoe J.C., Gallagher K., Ge W., Guo L., Guo X., Hager J., Haje P.K., Han J., Han T., Harbottle H.C., Harris S.C., Hatchwell E., Hauser C.A., Hester S., Hong H., Hurban P., Jackson S.A., Ji H., Knight C.R., Kuo W.P., LeClerc J.E., Levy S., Li Q.Z., Liu C., Liu Y., Lombardi M.J., Ma Y., Magnuson S.R., Maqsodi B., McDaniel T., Mei N., Myklebost O., Ning B., Novoradovskaya N., Orr M.S., Osborn T.W., Papallo A., Patterson T.A., Perkins R.G., Peters E.H., Peterson R., et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol. 24 (2006) 1151-1161
60. Slaper H., Velders G.J., Daniel J.S., de Gruijl F.R., and van der Leun J.C. Estimates of ozone depletion and skin cancer incidence to examine the Vienna Convention achievements. Nature 384 (1996) 256-258
61. Sugihara T., Magae J., Wadhwa R., Kaul S.C., Kawakami Y., Matsumoto T., and Tanaka K. Dose and dose-rate effects of low-dose ionizing radiation on activation of Trp53 in immortalized murine cells. Radiat. Res. 162 (2004) 296-307
62. Trougakos I.P., and Gonos E.S. Clusterin/apolipoprotein J in human aging and cancer. Int. J. Biochem. Cell Biol. 34 (2002) 1430-1448
63. Urzua U., Roby K.F., Gangi L.M., Cherry J.M., Powell J.I., and Munroe D.J. Transcriptomic analysis of an in vitro murine model of ovarian carcinoma: functional similarity to the human disease and identification of prospective tumoral markers and targets. J. Cell Physiol. 206 (2006) 594-602
64. Vankoningsloo S., De Pauw A., Houbion A., Tejerina S., Demazy C., de Longueville F., Bertholet V., Renard P., Remacle J., Holvoet P., Raes M., and Arnould T. CREB activation induced by mitochondrial dysfunction triggers triglyceride accumulation in 3T3-L1 preadipocytes. J. Cell Sci. 119 (2006) 1266-1282
65. Weichert W., Kristiansen G., Schmidt M., Gekeler V., Noske A., Niesporek S., Dietel M., and Denkert C. Polo-like kinase 1 expression is a prognostic factor in human colon cancer. World J. Gastroenterol. 11 (2005) 5644-5650
66. Weichert W., Kristiansen G., Winzer K.J., Schmidt M., Gekeler V., Noske A., Muller B.M., Niesporek S., Dietel M., and Denkert C. Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications. Virchows Arch. 446 (2005) 442-450
67. Weichert W., Schmidt M., Gekeler V., Denkert C., Stephan C., Jung K., Loening S., Dietel M., and Kristiansen G. Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades. Prostate 60 (2004) 240-245
68. Weitzman J.B., Fiette L., Matsuo K., and Yaniv M. JunD protects cells from p53-dependent senescence and apoptosis. Mol. Cell 6 (2000) 1109-1119
69. Wilson J.W., Deed R.W., Inoue T., Balzi M., Becciolini A., Faraoni P., Potten C.S., and Norton J.D. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index. Cancer Res. 61 (2001) 8803-8810
70. Zdanov S., Debacq-Chainiaux F., Remacle J., and Toussaint O. Identification of p38MAPK-dependent genes with changed transcript abundance in H2O2-induced premature senescence of IMR-90 hTERT human fibroblasts. FEBS Lett. 580 (2006) 6455-6463
71. Zhao J., Schmieg F.I., Simmons D.T., and Molloy G.R. Mouse p53 represses the rat brain creatine kinase gene but activates the rat muscle creatine kinase gene. Mol. Cell. Biol. 14 (1994) 8483-8492